Mechanisms of Vaccine Immunity against Coccidioidomycosis
Mechanisms of Vaccine Immunity against Coccidioidomycosis
批准号:
10591641
负责人:
BRUCE Steven KLEIN
金额:
$48.95万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-16 至 2023-01-31
关键词:
Advanced DevelopmentAntigen-Presenting CellsAntigensAttenuatedAttenuated VaccinesBlastomyces dermatitidisCD4 Positive T LymphocytesCalcineurinCanis familiarisCell Culture TechniquesCellsCellular ImmunityCoccidioidesCoccidioidomycosisDataDependenceDevelopmentElementsEpithelialEpithelial CellsEventFungal VaccinesGenerationsGenetic PolymorphismGrowthHost resistanceHumanImmuneImmunityImmunizeInfectionInfection ControlInflammatoryInflammatory ResponseInhalationInnate Immune ResponseKineticsKnowledgeLungLymphoid CellMeasuresMechanicsMediatingMedicalMemoryModelingMolecularMouse StrainsMucosal ImmunityMucous MembraneMusMycosesMyelogenousMyeloid CellsPPP3R1 genePatientsPeptidesPhenotypePreventive measurePublic HealthRegulationReportingReproduction sporesResistanceResistance developmentRoleShapesSignal PathwaySignal TransductionSiteStructure of parenchyma of lungSubunit VaccinesSurfaceSystemT-LymphocyteTestingTissuesTransgenic MiceTranslatingTranslationsVaccinatedVaccinationVaccine AntigenVaccinesWorkadaptive immune responsecytokinedectin 1draining lymph nodefungusinnovationinsightmemory CD4 T lymphocytemucosal vaccinationmucosal vaccinenovelpathogenpulmonary functionresponserestrainttooltranscriptometranscriptomicsvaccine delivery
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
We will exploit a live attenuated ∆cps1 (null) strain of Coccidiodes posadasii to vaccinate against coccidiodomycosis, and
elucidate the mechanics by which the lung epithelium coordinates the induction of durable T cell immunity against infection.
Host resistance against inhaled pathogens is thought to reside with lung tissue-resident memory (TRM) cells and mucosal
immunity, but little is known about whether or how a fungal vaccine creates resident T cell immunity at the lung mucosa.
Our preliminary data reveal that mucosal vaccination elicits protective, Coccidioides endoglucanase 2 (C-Eng2) specific
CD4+ T cells and that the lung epithelium is required to mobilize myeloid and lymphoid cells in response to the vaccine.
This network of stromal and hematopoetic cell responses to vaccination has not been studied and is the subject of this project.
To define cellular and molecular mechanisms required to elicit protective immunity at the lung mucosa, we have created
innovative tools: i) a novel protective antigen C-Eng2 and peptide:MHCII tetramers to track and enumerate protective CD4+
T cells in C57BL6 in mice; ii) transgenic mice in which epithelial cells and their products are able to be conditionally deleted
to dissect their role in generation of immunity; and (iii) a novel system of isolating and culturing human lung epithelium to
translate results from mice to humans. We hypothesize that the mucosal delivery of ∆cps1 vaccine spores promotes devel-
opment of protective TRM cells and that the lung epithelium coordinates durable protective immunity. We aim to:
1. Probe the intial stages of vaccine recognition and response by innate immune cells in lung. We will test the hypothesis
that lung epithelium and their products regulate mobilization of innate immune cells that recognize and restrain growth
of ∆cps1 vaccine spores, and also captures them to present their peptides to naïve T cells in the draining lymph nodes.
2. Elucidate intracellular signaling pathway during lung epithelial cell regulation of innate response to ∆cps1 vaccine.
We will test the hypothesis that Ca++ and calcineurin dependent signaling events within the lung epithelium contribute
to the dectin-1 dependency of host inflammatory responses to Coccidiodes spp. and vaccine in both mice and humans.
3. Define mechanisms of durable T cell immunity elicited by vaccination at the lung mucosa. We will test the hypothesis
that lung epithelium shapes the phenotypic, functional and transcriptomic features of protective C-Eng2-specific CD4+
T cells following intransal administration ∆cps1 vaccine spores .
Our work will exploit a highly effective vaccine against coccidioidomycosis to elucidate the mechanisms of lung immunity
following mucosal administration. Little is known about the mechanisms of vaccine-induced protective immunity at the
lung mucosa, and how the lung epithelium regulates the early recognition and restraint of vaccine spores and generation of
protective T cells. Vaccination against coccidioidomycosis, an important public health problem, is a major unmet medical
need. We anticipate that new insight into the mechanistic underpinnings of vaccine induced mucosal resistance, and the
immune correlates of vaccine resistance will advance the development of preventive measures against coccidioidomycosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of vaccine immunity against coccidioidomycosis
-
批准号:10584260
-
项目类别:
-
资助金额:$53.58万
-
财政年份:2023
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Mode of Action Core
-
批准号:10571218
-
项目类别:
-
资助金额:$51.13万
-
财政年份:2019
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Mode of Action Core
-
批准号:10592385
-
项目类别:
-
资助金额:$76.39万
-
财政年份:2019
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Lung epithelial cell regulation of immunity to inhaled fungi
-
批准号:10222492
-
项目类别:
-
资助金额:$46.17万
-
财政年份:2018
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Lung epithelial cell regulation of immunity to inhaled fungi
-
批准号:10451274
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2018
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Lung epithelial cell regulation of immunity to inhaled fungi
-
批准号:9975090
-
项目类别:
-
资助金额:$46.17万
-
财政年份:2018
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens
-
批准号:10614603
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2016
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens
-
批准号:10224468
-
项目类别:
-
资助金额:$59.95万
-
财政年份:2016
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens
-
批准号:10544356
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2016
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens
-
批准号:10448406
-
项目类别:
-
资助金额:$64.75万
-
财政年份:2016
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Tracking anti-fungal CD4+ T cells in vivo
-
批准号:8610881
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2013
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Tracking anti-fungal CD4+ T cells in vivo
-
批准号:8495679
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2013
-
负责人:BRUCE Steven KLEIN
-
依托单位:
TR4 ANALYSIS IN THE PRESENCE AND ABSENCE OF CALCIUM
-
批准号:8361171
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2011
-
负责人:BRUCE Steven KLEIN
-
依托单位:
TRAINING IN THE USE OF BRUKER AND VARIAN SPECTROMETERS AND NMR
-
批准号:8361175
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2011
-
负责人:BRUCE Steven KLEIN
-
依托单位:
TR4 ANALYSIS IN THE PRESENCE AND ABSENCE OF CALCIUM
-
批准号:8168974
-
项目类别:
-
资助金额:$1.84万
-
财政年份:2010
-
负责人:BRUCE Steven KLEIN
-
依托单位:
TRAINING IN THE USE OF BRUKER AND VARIAN SPECTROMETERS AND NMR
-
批准号:8168979
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2010
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Targeting hybrid histidine kinase for broad spectrum antifungal therapy
-
批准号:7936212
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2009
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Targeting hybrid histidine kinase for broad spectrum antifungal therapy
-
批准号:7812372
-
项目类别:
-
资助金额:$49.89万
-
财政年份:2009
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Antifungal Memory Immunity
-
批准号:6841401
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2004
-
负责人:BRUCE Steven KLEIN
-
依托单位:
Microbes in Health and Disease
-
批准号:10400928
-
项目类别:
-
资助金额:$44.45万
-
财政年份:2003
-
负责人:BRUCE Steven KLEIN
-
依托单位:
海外基金